↓ Skip to main content

PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma

Overview of attention for article published in Frontiers in oncology, August 2022
Altmetric Badge

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
6 Mendeley